ArticleNPJ precision oncology2026

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

Marie-Elisabeth Leßmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.